Interní Med. 2007; 9(9): 392-393

Precanserous of oesophagus and gastric

MUDr. Jiří Dolina Ph.D, MUDr. Jitka Prokešová, MUDr. Radek Kroupa, prof. MUDr. Aleš Hep CSc
III. interní klinika gastroenterologická, FN Brno-Bohunice

Specialised intestinal metaplasia within the oesophagus (Barrett´s osesophagus) is known to have malignant potential, predisposing patients to subsequent development of oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma is rising. Detection of dysplasia in biopsy specimens is a pathological criterion for identifying patients who are at increased risk for developing adenocarcinoma. Gastric cancer was the most common malignant disease as recently as 1950s. Since then, there has been a dramatic decrease in the death rate from this disease. There is a marked variation in the incidence of gastric cancer throughout the world.

Keywords: Barrett´s oesophagus, gastric cancer

Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dolina J, Prokešová J, Kroupa R, Hep A. Precanserous of oesophagus and gastric. Interní Med. 2007;9(9):392-393.
Download citation

References

  1. Giuli R et al. Barrett´s esophagus. John Libbey Eurotext 2003; 433 s.
  2. Hunt RH. Will eradication of HP infection influence the risk of gastric cancer? AMJ. 2004; 117/Suppl 5A: 87-91. Go to original source... Go to PubMed...
  3. Jurgoš L a kol. Gastroenterolológia. Bratislava, VEDA 2006; 688 s.
  4. Kala Z a kol. Refluxní choroba jícnu - diagnostika a chirurgická léčba. Grada Publishing 2003; 148 s.
  5. Keighley MRB. Gastrointestinal cancers in Europe. Aliment Pharmacol Ther. 2003; 18: Suppl 3, 7-31. Go to original source... Go to PubMed...
  6. Mařatka, Z. Gastroenterologie, Nakladatelství Karolinum 1999; 473 s.
  7. O´Connor H, Sebastian S. The burden of HP infection in Europe. Aliment Pharmacol Ther. 2003; 18: Supp 3, 38-45. Go to original source... Go to PubMed...
  8. Sleisenger MH, Fordtran JS. Gastrointestinal Disease. WB Saunders comp 1989; 986 s.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.